Effects of stem cells transplantation on immune function, liver function and related indexes in patients with end-stage liver disease
10.3969/j.issn.1671-8348.2017.18.015
- VernacularTitle:干细胞移植对终末期肝病患者免疫、肝功能及相关指标的影响
- Author:
Yuzhuo WU
;
Le YANG
;
Yufeng ZHAI
;
Huaihong ZHANG
;
Liya HUO
- Keywords:
bone marrow;
end-stage liver disease;
mesenchymal stem cell transplantation;
immune function;
liver function;
alpha-fetoproteins;
plasma total protein;
prothrombin activity rate
- From:
Chongqing Medicine
2017;46(18):2492-2494
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of stem cells transplantation on immune function,liver function and related indexes in the patients with end-stage liver disease(ESLD).Methods A total of 163 cases of ESLD in Nanyang Municipal Central Hospital of Affiliated Hospital of Zhengzhou University were selected and divided into 2 groups by the randomized single blind method.Eighty-one cases in the control group were given the conventional symptomatic treatment,while 82 cases in the observation group received bone marrow mesenchymal stem cell(BMSC) transplantation based on the control group.The changes of immune function,liver function,alpha fetoprotein(AFP),rate of prothrombin activity(PTA) and plasma total protein(TP) level before and after treatment were observed in the two groups.Results The immune function indexes CD3+,CD4+,CD8+,CD4+/CD8+,TP and PTA levels after treatment in the observation group were significantly higher than those before treatment and in the control group (P＜0.05),while the levels of AFP,alanine aminotransferase (ALT),aspartate aminotransferase (AST) and total bilirubin (TBIL)were lower than those before treatment in the same group and the control group(P＜0.05).There was no statistically significant difference in complication occurrence rate between the two groups(P＞0.05).Conclusion BMSC transplantation for treating ESLD can improve the immune function,improves the liver function and reduces the AFP level.
